Kaken Pharmaceutical Co Ltd 2024 IR

The report outlines Kaken Pharmaceutical's value creation process and sustainability strategy for fiscal year 2023. Key highlights include the launch of NexoBrid, a first-in-class drug for burn eschar removal, and the introduction of a new twist bottle for Ecclock to improve patient convenience. The company also advanced its global expansion, initiating Phase I clinical trials for KP-001 in the United States. On the environmental front, Kaken reduced its Scope 1 and 2 CO2 emissions to 21,408 t-CO2 and increased its use of carbon-free electricity to 18%. Additionally, the company established its Human Rights Policy and Sustainable Procurement Policy to strengthen its business foundation.

Company: Kaken Pharmaceutical Co Ltd

Sector: Health Care

Country: Japan

Year: 2024

Type: IR

Pages: 51

Back to company

Kaken Pharmaceutical Co Ltd

Kaken Pharmaceutical Co Ltd 2024 Corporate Report

Corporate Report

The report outlines Kaken Pharmaceutical's value creation process and sustainability strategy for fiscal year 2023. Key highlights include the launch of NexoBrid, a first-in-class drug for burn eschar removal, and the introduction of a new twist bottle for Ecclock to improve patient convenience. The company also advanced its global expansion, initiating Phase I clinical trials for KP-001 in the United States. On the environmental front, Kaken reduced its Scope 1 and 2 CO2 emissions to 21,408 t-CO2 and increased its use of carbon-free electricity to 18%. Additionally, the company established its Human Rights Policy and Sustainable Procurement Policy to strengthen its business foundation.

Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.

Document Details

Report Year

2024

Reporting Period

Apr 1, 2023 - Mar 31, 2024

Fiscal Year

2023

Type

Integrated Report

Language

English

Pages

 

File Size

 

Standards & Assurance

Reporting Standards

Materiality Assessment

ESG Data?Experimental — AI-extracted data, may contain inaccuracies

Renewable Energy

Water Consumption

Total Waste

Women on Board

Women in Management

Net Zero Target

Employees